Crossmark

TRAC in vivo: culmination of CAR and vector engineering

Crossref DOI link: https://doi.org/10.1038/s41422-026-01255-3

Published Online: 2026-05-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cabriolu, Annalisa

Sadelain, Michel https://orcid.org/0000-0002-9031-8025
License Information

Text and Data Mining valid from 2026-05-25

Version of Record valid from 2026-05-25
More Information

Article History

First Online: 25 May 2026

Competing interests

: M.S. holds patents related to CAR T cell therapies. A.C. declares no competing interest.